Crystalline ultrastructures, inflammatory elements, and neoangiogenesis are present in inconspicuous aortic valve tissue.
Morbidity from calcific aortic valve disease (CAVD) is increasing. Recent studies suggest early reversible changes involving inflammation and neoangiogenesis. We hypothesized that microcalcifications, chemokines, and growth factors are present in unaffected regions of calcific aortic valves. We studied aortic valves from 4 patients with CAVD and from 1 control, using immunohistochemistry, scanning electron microscopy, and infrared spectrography. We revealed clusters of capillary neovessels in calcified (ECC), to a lesser extent in noncalcified (ECN) areas. Endothelial cells proved constant expression of SDF-1 in ECC, ECN, and endothelial cells from valvular surface (ECS). Its receptor CXCR4 was expressed in ECC. IL-6 expression correlated with CXCR4 staining and presence of lymphocytes. VEGF was expressed by ECS, its receptor by ECC and ECN. Crystalline ultrastructures were found on the surface of histologically noncalcified areas (HNCAs), spectrography revealed calcium hydroxylapatite. Our results demonstrate that crystalline ultrastructures are present in HNCAs, undergoing neoangiogenesis in an inflammatory context. These alterations could be an early witness of disease and an opening to therapy.
Service d'Anatomie et de Cytologie Pathologiques, Hôpital de la Pitié-Salpêtrière, 47-80 Boulevard de l'Hôpital, Assistance Publique-Hôpitaux de Paris, Université Pierre et Marie Curie, 75013 Paris, France.
P
P
Dorfmüller
D
D
Bazin
S
S
Aubert
R
R
Weil
F
F
Brisset
M
M
Daudon
F
F
Capron
I
I
Brochériou
J Exp Med. 1996 Sep 1;184(3):1101-9
9064327
Am J Cardiol. 1989 Feb 15;63(7):471-7
2916433
Circ Res. 2005 Apr 15;96(7):792-9
15761200
Ann Med. 2009;41(4):257-64
19089693
Langmuir. 2007 Mar 27;23(7):4005-11
17316032
J Biol Chem. 1994 Jan 7;269(1):232-7
8276799
Arterioscler Thromb Vasc Biol. 2009 Feb;29(2):254-60
19023092
Anat Embryol (Berl). 1985;172(1):61-7
4037373
Nat Med. 2003 Jun;9(6):669-76
12778165
Ann Thorac Cardiovasc Surg. 2002 Feb;8(1):24-30
11916439
Nature. 1996 Aug 29;382(6594):829-33
8752280
Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1721-8
16709942
Am J Cardiol. 2004 Dec 1;94(11):1396-402, A6
15566910
J Mol Med (Berl). 2009 Jan;87(1):17-24
18766323
J Mol Med (Berl). 2008 Nov;86(11):1221-32
18690419
Circ Res. 2008 Aug 29;103(5):e28-34
18669918
J Clin Invest. 2000 Jan;105(1):101-11
10619866
Circulation. 2005 Jun 21;111(24):3296-301
15956138
Exp Cell Res. 2007 Jul 1;313(11):2326-35
17475245
Arterioscler Thromb Vasc Biol. 2007 Feb;27(2):275-82
17158356
Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):1897-908
18566299
Nat Med. 2006 May;12(5):557-67
16648859
Am J Cardiol. 2006 May 15;97(10):1502-5
16679093
J Am Coll Cardiol. 2008 Sep 2;52(10):843-50
18755348
Med Hypotheses. 2007;68(6):1233-5
17011715
Clin Chim Acta. 2000 Aug;298(1-2):1-11
10876000
Circulation. 2001 Mar 20;103(11):1522-8
11257079
Eur Heart J. 2005 Dec;26(23):2576-80
16115807
Exp Cell Res. 2004 Aug 15;298(2):455-64
15265693
Nature. 1996 Aug 29;382(6594):833-5
8752281
Circulation. 2004 Sep 7;110(10):1291-5
15337704
Genomics. 1993 Jun;16(3):707-12
8325644
Heart. 2001 Jan;85(1):13-7
11119453
J Mater Sci Mater Med. 2002 Sep;13(9):885-9
15348554
J Heart Valve Dis. 2008 Jul;17(4):388-95
18751468
J Exp Med. 1997 Jan 6;185(1):111-20
8996247
Int Immunol. 1993 Oct;5(10):1239-49
7505609